Anbio Biotechnology (NNNN)
NASDAQ: NNNN · Real-Time Price · USD
34.41
-0.03 (-0.09%)
At close: May 29, 2026, 4:00 PM EDT
34.85
+0.44 (1.26%)
After-hours: May 29, 2026, 4:10 PM EDT
Anbio Biotechnology Market Cap
Anbio Biotechnology has a market cap or net worth of $1.51 billion as of May 29, 2026. Its market cap has increased by 389.47% in one year.
Market Cap
1.51B
Enterprise Value
1.50B
1-Year Change
389.47%
Ranking
Category
Stock Price
$34.41
Market Cap Chart
Since the IPO on February 19, 2025, Anbio Biotechnology's market cap has increased from $219.46M to $1.51B, an increase of 588.20%. That is a compound annual growth rate of 356.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 1.51B | 14.43% |
| Dec 31, 2025 | 1.32B | 501.40% |
| Feb 19, 2025 | 219.46M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MiniMed Group | 3.03B |
| LeMaitre Vascular | 2.19B |
| DENTSPLY SIRONA | 2.00B |
| Pulse Biosciences | 1.71B |
| STAAR Surgical Company | 1.56B |
| AtriCure | 1.39B |
| Alamar Biosciences | 1.33B |
| Kestra Medical Technologies | 1.23B |